PVLA

Palvella Therapeutics, Inc. Common Stock
PVLA

Overview Fund Activity

24 hedge funds and large institutions have $28.3M invested in Palvella Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 8 closing their positions.

Holders
24
Holders Change
-5
Holders Change %
-17.24%
% of All Funds
0.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
6
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
1
BVF Inc
California
$2.61M
2
Morgan Stanley
2
Morgan Stanley
New York
$256K
3
RC
3
RBF Capital
California
$45K
4
Creative Planning
4
Creative Planning
Kansas
$65K
5
VKH
5
Virtu KCG Holdings
New York
$20K

Top Sellers

1
LOAMU
1
Lombard Odier Asset Management (USA)
New York
$3.41M
2
SM
2
Sabby Management
Florida
$1.81M
3
OFM
3
Omega Fund Management
Massachusetts
$2.38M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$0
5
Deutsche Bank
5
Deutsche Bank
Germany
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Deutsche Bank
26
Deutsche Bank
Germany
– -$63K -433 Closed
RJA
27
Raymond James & Associates
Florida
– -$55K -375 Closed
Northern Trust
28
Northern Trust
Illinois
– -$46K -313 Closed
FWM
29
Frontier Wealth Management
Missouri
– -$46K -313 Closed
Millennium Management
30
Millennium Management
New York
– -$33K -228 Closed
JPMorgan Chase & Co
31
JPMorgan Chase & Co
New York
– -$32K -219 Closed
TRCT
32
Tower Research Capital (TRC)
New York
– -$6K -40 Closed
1
2